Literature DB >> 2985862

Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.

G Hunsmann, J Schneider, H Bayer, R Kurth, A Werner, H D Brede, V Erfle, W Mellert, H R Brodt, L Bergmann.   

Abstract

In 1984 10,281 sera were collected in the FRG and examined for antibodies to HTLV-III (LAV) with an enzyme-linked immunosorbent assay and confirmative tests. Of the German AIDS patients 81% have antibodies. Individuals belonging to AIDS risk groups, homosexuals, haemophiliacs and i.v. drug abusers, have antibody frequencies between 25%-72%. The detection of HTLV-III antibodies in blood donors indicates that the virus is being transmitted by blood transfusions.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2985862     DOI： 10.1007/bf01731176

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  25 in total

1.  Heterosexual partners: a large risk group for AIDS.

Authors:  D C Des Jarlais; M E Chamberland; S R Yancovitz; P Weinberg; S R Friedman
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

2.  Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany.

Authors:  R Hehlmann; G Kreeb; V Erfle; H Piechowiak; G Krüger; F D Goebel
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

3.  Increase in prevalence of anti-HTLV-III in haemophiliacs.

Authors:  L G Gürtler; D Wernicke; J Eberle; G Zoulek; F Deinhardt; W Schramm
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

4.  Infection of chimpanzees with lymphadenopathy-associated virus.

Authors:  D P Francis; P M Feorino; J R Broderson; H M McClure; J P Getchell; C R McGrath; B Swenson; J S McDougal; E L Palmer; A K Harrison
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

5.  A glycopolypeptide (gp 100) is the main antigen detected by HTLV-III antisera.

Authors:  J Schneider; H Bayer; U Bienzle; G Hunsmann
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

6.  Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

Authors:  D Klatzmann; F Barré-Sinoussi; M T Nugeyre; C Danquet; E Vilmer; C Griscelli; F Brun-Veziret; C Rouzioux; J C Gluckman; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

7.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

8.  [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].

Authors:  D Wernicke; K v d Helm; J Abb; J Eberle; G Zoulek; G Pleyl; F Deinhardt; G Riethmüller; H W Ziegler-Heitbrock; E P Rieber
Journal:  Dtsch Med Wochenschr       Date:  1984-11-09       Impact factor: 0.628

9.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.

Authors:  H J Alter; J W Eichberg; H Masur; W C Saxinger; R Gallo; A M Macher; H C Lane; A S Fauci
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728
View more
  8 in total

1.  [AIDS and HTLV-III in West Germany: the status February 1985].

Authors:  R Hehlmann; V Erfle; G Hunsmann; R Kurth
Journal:  Klin Wochenschr       Date:  1985-05-02

2.  HIV-specific antibody among voluntary blood donors in Lower Saxony (FRG).

Authors:  G Caspari; J Beyer; F Schunter; J Knüver-Hopf; H Schmitt
Journal:  Blut       Date:  1987-09

3.  Risk factors for HIV infection in German i.v. drug abusers. Clinical, serological and epidemiological features.

Authors:  G Harms; U Laukamm-Josten; U Bienzle; I Guggenmoos-Holzmann
Journal:  Klin Wochenschr       Date:  1987-04-15

4.  [AIDS fatalities in Hamburg (status: February 1985)--legal medicine aspects].

Authors:  K Püschel; K Tenner-Racz; P Racz; M Dietrich; P Kern; H Schmitz; K Lieske
Journal:  Z Rechtsmed       Date:  1985

5.  HTLV III antibodies and immunological alterations in hemophilia patients.

Authors:  E Seifried; G Pindur; H Stötter; F Porzsolt; H Rasche; V Erfle; R Hehlmann; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-02-03

6.  HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a North-German drug clinic.

Authors:  G Paschelke; G Altvater-Kremer; W D Meyer; H Kremer
Journal:  Klin Wochenschr       Date:  1987-01-05

7.  Prevalence of HIV antibodies in groups at risk in Zürich, Switzerland.

Authors:  J Blaser; R Lüthy; S Rietiker; B Ledergerber; M G Täuber
Journal:  Klin Wochenschr       Date:  1987-03-02

8.  Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products.

Authors:  V Erfle; R Hehlmann; W Mellert; F D Goebel; H Rasokat; E Lechler; P Hellstern; M Köhler; E Seifried; H Heimpel
Journal:  Blut       Date:  1985-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.